Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #73996 on PharmaCyte Biotech Inc (PMCB)
DragonBear
08/20/17 12:28 PM
#73998 RE: PINKribbon #73996
NEW YORK, NY--(Marketwired - Nov 5, 2013) - Nuvilex, Inc. (OTCQB: NVLX) made an announcement yesterday that should have investors excited that the company's Phase 3 clinical trials may have unofficially just started.
IND certainly coming.
btw, if you'll just dig a little deeper, you'll learn that under FDA CiaB is device...didn't mean to bust your bubble.
Also note a "pivotal trial" or study pertains to medical devices, and their safety. In PMCB's case that would cover CIAB beads.